News & Events
Early treatment benefits individuals with a first attack resembling MS
People diagnosed with CIS who received early treatment are less likely to convert to MS
A simple specialised eye examination can show the effect of MS drugs
Optical coherence tomography may be used to test the effect of drugs in relapsing-remitting MS trials
Early evidence of multiple sclerosis in high risk family members
Some family members of people with MS show possible early signs of the disease without symptoms
Biomarker for predicting MS risk after clinically isolated syndrome
A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS
7th Russian patients congress
The 7th All-Russian Congress of patients was held in Moscow and attended by over 424 delegates
Portuguese Politicians experience MS symptoms
National Multiple Sclerosis Day marked across Portugal
Neonatal vitamin D and the risk of MS
Further evidence shows the role of vitamin D in MS risk, especially during pregnancy
Recruitment complete for new progressive MS drug trial
250 people with progressive MS are taking part in the SPRINT-MS trial for ibudilast
Research highlights of 2016
Professor Alan Thompson highlights some of 2016’s research discoveries in MS
Tawasol – December 2016 issue
Issue 17: 11 organisations from the Arab region share their news
400 young people gather in Rome to learn about MS
‘Young people beyond MS’
No link between NR1H3 p.Arg415Gln and multiple sclerosis risk
A new study fails to replicate the role of a gene in developing primary progressive MS